Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Stopping aripiprazole can reverse its side effect of hair loss.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride may help treat female hair loss, but has risks.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

5-ARI therapy may help prevent prostate cancer progression.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Urologists should screen for mental health issues before and during finasteride treatment.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.